The enantiomeric purity of l-DOPA may be analyzed by determination of the optical rotation or by chiral thin-layer chromatography. As is true for many molecules, the human body produces only one of these isomers (the l-DOPA form). L-DOPA has a counterpart with opposite chirality, d-DOPA. As a drug, it is used in the clinical treatment of Parkinson's disease and dopamine-responsive dystonia. l-DOPA can be manufactured and in its pure form is sold as a psychoactive drug with the INN levodopa trade names include Sinemet, Pharmacopa, Atamet, and Stalevo.
Furthermore, l-DOPA itself mediates neurotrophic factor release by the brain and CNS. l-DOPA is the precursor to the neurotransmitters dopamine, norepinephrine (noradrenaline), and epinephrine (adrenaline), which are collectively known as catecholamines. Humans, as well as a portion of the other animals that utilize l-DOPA, make it via biosynthesis from the amino acid l-tyrosine. L-DOPA, also known as levodopa and l-3,4-dihydroxyphenylalanine, is an amino acid that is made and used as part of the normal biology of some plants and animals, including humans.
